These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model. Chang HH; Chen BY; Wu CY; Tsao ZJ; Chen YY; Chang CP; Yang CR; Lin DP J Biomed Sci; 2011 Jan; 18(1):6. PubMed ID: 21241512 [TBL] [Abstract][Full Text] [Related]
5. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines. Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788 [TBL] [Abstract][Full Text] [Related]
6. New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. Lee SO; Ma Z; Yeh CR; Luo J; Lin TH; Lai KP; Yamashita S; Liang L; Tian J; Li L; Jiang Q; Huang CK; Niu Y; Yeh S; Chang C J Mol Cell Biol; 2013 Feb; 5(1):14-26. PubMed ID: 22831834 [TBL] [Abstract][Full Text] [Related]
7. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis. Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352 [TBL] [Abstract][Full Text] [Related]
8. Androgen action during prostate carcinogenesis. Wang D; Tindall DJ Methods Mol Biol; 2011; 776():25-44. PubMed ID: 21796518 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer. Shiota M; Yokomizo A; Naito S Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046 [TBL] [Abstract][Full Text] [Related]
10. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor. Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034 [TBL] [Abstract][Full Text] [Related]
11. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Li L; Dang Q; Xie H; Yang Z; He D; Liang L; Song W; Yeh S; Chang C Oncotarget; 2015 Jun; 6(16):14179-90. PubMed ID: 25895025 [TBL] [Abstract][Full Text] [Related]
12. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer. Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914 [TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells. Gao W; Wang Y; Yu S; Wang Z; Ma T; Chan AM; Chiu PK; Ng CF; Wu D; Chan FL Stem Cell Res Ther; 2022 May; 13(1):188. PubMed ID: 35526071 [TBL] [Abstract][Full Text] [Related]
15. Embryonic microenvironment suppresses YY1 and YY1-related genes in prostate cancer stem cells. Taskiran A; Oktem G; Demir A; Oltulu F; Ozcinar E; Duzagac F; Guven U; Karakoc E; Cakir A; Ayla S; Guven S; Acikgoz E Pathol Res Pract; 2024 Aug; 260():155467. PubMed ID: 39047662 [TBL] [Abstract][Full Text] [Related]
16. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer. Bohrer LR; Chen S; Hallstrom TC; Huang H Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251 [TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review). Contreras HR; López-Moncada F; Castellón EA Int J Oncol; 2020 May; 56(5):1075-1082. PubMed ID: 32319606 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness. Liu X; Li WJ; Puzanov I; Goodrich DW; Chatta G; Tang DG Essays Biochem; 2022 Sep; 66(4):291-303. PubMed ID: 35866337 [TBL] [Abstract][Full Text] [Related]
19. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity. Vummidi Giridhar P; Williams K; VonHandorf AP; Deford PL; Kasper S Cancer Res; 2019 Mar; 79(6):1124-1137. PubMed ID: 30626627 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancer stem cells: the role of androgen and estrogen receptors. Di Zazzo E; Galasso G; Giovannelli P; Di Donato M; Di Santi A; Cernera G; Rossi V; Abbondanza C; Moncharmont B; Sinisi AA; Castoria G; Migliaccio A Oncotarget; 2016 Jan; 7(1):193-208. PubMed ID: 26506594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]